Advisornet Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Advisornet Financial’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,573	Closed	-$2.31K	–	2316
2025 Q1	$2.31K	Hold	1,573	–	–	﹤0.01%	1764
2024 Q4	$6.97K	Buy	1,573 +263	+20%	+$1.07K	﹤0.01%	1403
2024 Q3	$5.4K	Buy	+1,310	New	+$7.04K	﹤0.01%	1565
2024 Q1	–	Sell	-19	Closed	-$217	–	2278
2023 Q4	$217	Buy	+19	New	+$188	﹤0.01%	2282
2023 Q3	–	Sell	-23	Closed	-$245	–	2350
2023 Q2	$245	Sell	23 -3	-12%	-$32	﹤0.01%	2190
2023 Q1	$274	Buy	26 +1	+4%	+$11	﹤0.01%	2200
2022 Q4	$310	Buy	+25	New	+$284	﹤0.01%	2128

Other funds holding IRWD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Advisornet Financial's IRWD Position: Q2 2025 in Review

Advisornet Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 1,573 shares — an estimated $2.31K sold.

Advisornet Financial first reported a position in IRWD in Q4 2022 and held it in 7 quarters. The position peaked at $6.97K in Q4 2024. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

Advisornet Financial reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Advisornet Financial sold 1,573 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $2.31K.
Advisornet Financial first reported a position in Ironwood Pharmaceuticals in Q4 2022 and held it in 7 quarters.
Advisornet Financial's Ironwood Pharmaceuticals position peaked at $6.97K in Q4 2024.
155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Advisornet Financial's 13F filing for Q2 2025, filed 14 Jul 2025.